PTBP1和癌症:从RNA调节到治疗潜力
Chengdong Ji1, Jing Zhu2, Xiaochen Hou2
1Pathology Department, The Ninth People's Hospital of Suzhou, Suzhou, China.
Journal of cellular and molecular medicine
|June 28, 2025
概括
聚胺系结合蛋白1 (PTBP1) 是一种RNA结合蛋白,对基因调节和瘤进展至关重要. 这篇评论探讨了PTBP1的研究.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 在RNA生物学,RNA生物学.
背景情况:
- 聚皮里米丁管结合蛋白1 (PTBP1) 是一种RNA结合蛋白,参与mRNA处理和非编码RNA功能.
- PTBP1在瘤发生和癌症进展中起着重要作用.
- PTBP1是癌症治疗的潜在目标.
研究的目的:
- 审查PTBP1在各种瘤中的结构,功能和作用.
- 阐明PTBP1在癌症中的作用的关键机制.
- 讨论PTBP1研究和临床翻译的挑战和未来方向.
主要方法:
- 关于PTBP1结构和功能的文献综述.
- 对PTBP1在不同类型癌症中的参与进行分析.
- 检查PTBP1在瘤发生中的机械作用.
- 讨论临床翻译潜力和未来的研究途径.
主要成果:
- PTBP1调节mRNA拼接,稳定性,局部化和翻译.
- PTBP1通过各种机制影响瘤发生和癌症进展.
- 在瘤学中,PTBP1具有作为治疗点的潜力.
结论:
- PTBP1是癌症的关键调节剂,影响多个细胞过程.
- 了解PTBP1机制对于开发向癌症疗法至关重要.
- 对PTBP1的进一步研究有望促进精确瘤学的发展.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
Regulation of Expression at Multiple Steps
1.0K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


